USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: MERCATOR MEDSYSTEMS, INC.
Address: 1670 Alvarado Street
SAN LEANDRO, CA 94577-
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $411,624.00 2
SBIR Phase II $2,048,720.00 1
STTR Phase I $218,055.00 1
STTR Phase II $1,148,429.00 1

Award List:

Adventitial Paclitaxel to Delay Post-Intervention Dialysis Graft Stenosis

Award Year / Program / Phase: 2007 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kirk Seward
Award Amount: $194,215.00
Abstract:
DESCRIPTION (provided by applicant): Hemodialysis vascular access dysfunction as a result of stenosis at the graft-vein anastomosis of dialysis access grafts is currently a huge clinical problem for the estimated 350,000 patients on hemodialysis in the Uni ted States. Despite the magnitude of the… More

Improved Adventitial Sirolimus Therapy for Peripheral Artery Restenosis

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kirk Seward
Award Amount: $217,409.00
Abstract:
DESCRIPTION (provided by applicant): Peripheral artery disease (PAD) affects 9 to 12 million Americans [1] and 1.5 million will require an intervention (407,400 receive bypass or amputation; 1,080,000 receive angioplasty, stent or atherectomy) each year [ 3]. Unfortunately, only one-third of… More

Broncho-adventitial Drug Delivery: Paclitaxel for Bronchial Carcinoma

Award Year / Program / Phase: 2011 / STTR / Phase II
Agency: HHS
Research Institution: STEWARD RESEARCHAND OTHER SPECIAL PROJECT CORPORATION
Principal Investigator: Kirk Seward – 510-614-4555
Award Amount: $1,148,429.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Over 215,000 people will be diagnosed in 2008 with bronchial carcinoma in the U.S. according to the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. Currently, asthma afflicts22.9 million people in the U.S., and… More

Improved Adventitial Rapamycin Therapy for Peripheral Artery Restenosis

Award Year / Program / Phase: 2013 / SBIR / Phase II
Agency: HHS
Principal Investigator: Kirk Seward – 510-614-4555
Award Amount: $2,048,720.00
Abstract:
DESCRIPTION (provided by applicant): Peripheral artery disease (PAD) affects 9 to 12 million Americans [1] and 1.5 million will require an intervention (407,400 receive bypass or amputation; 1,080,000 receive angioplasty, stent or atherectomy) each year [3]. Unfortunately, only one-third of… More